Pancreatic cancer is one of the most aggressive cancers and has one of the lowest survival rates—only 10% after five years.

The Lupus Foundation of America (LFA) is excited to share that enrollment for the MiSLE (Mesenchymal Stromal Cells in ...

Gastrointestinal Stromal Tumor Market to Grow Rapidly During the Study Period (2020–2034) Owing to the Launch of Emerging Therapies | DelveInsight According to DelveInsight’s analysis, the market for ...

Pancreatic cancer is one of the most aggressive cancers and has one of the lowest survival rates-only 10% after five years.

NeuroScientific Biopharmaceuticals (ASX: NSB) has announced its acquisition of Isopogen WA, gaining the StemSmart patented stem cell technology for manufacturing mesenchymal stromal cells (MSC). The ...

Independent Data Safety Monitoring Board (DSMB) recommends that the study proceeds as designed based on 30-day data safety assessment of ...

Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on the status of its products in relation to the U.S. Government’s ...

with a higher proportion of so-called epithelial cells and a lower proportion of stromal cells in the uteruses of women with PCOS. "These results show that the growth of the cells is affected ...

Chemokines, our body's chemical messengers, play a crucial role in regulating the immune response.  They are secreted by ...